Mukka Proteins Limited has informed the Exchange regarding a press release dated February 13, 2026, titled "Mukka Proteins Limited Reports Strong Q3 & 9M FY26 Performance".
MUKKA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mukka Proteins reported Q3 FY26 consolidated revenue of ₹653.50 crore, more than doubling from ₹303.15 crore in Q3 FY25 (up 115.57% YoY) and rising 167.19% QoQ. EBITDA grew 11.61% YoY to ₹53.21 crore but margins slipped to 8.14% from 15.73% a year ago, reflecting higher costs despite strong top-line growth. PAT was nearly flat at ₹27.25 crore (up 1.69% YoY) with margins at 4.17%. For 9M FY26, revenue rose 71.06% to ₹1,068.85 crore while PAT grew modestly 4.78% to ₹35.73 crore. The company also bagged a ₹474.89 crore order from Bengaluru Solid Waste Management Limited for legacy leachate treatment, and its 300 TPD wet-waste processing operations got Verra carbon credit listing with additional 1,000 TPD capacity approved.
Strong revenue growth signals demand recovery and successful diversification, but the sharp drop in EBITDA and PAT margins may worry investors looking at profitability. The ₹474.89 crore BSWML order provides significant revenue visibility and marks a meaningful entry into the waste-management vertical. Near-term stock reaction is likely to be mixed — positive on growth momentum and new order, cautious on margin compression.